Long-lasting and clinically proven solutions for bladder and bowel control
Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to improve the quality of life for patients suffering from urinary and bowel dysfunction.
Axonics SNM offers a long-lasting therapy option that is easy-to-use and clinically proven to help people regain bladder and bowel control.1
The 
Advantage
Unique Composition
Homogenous hydrogel consisting of 97.5% water and 2.5% cross-linked polyacrylamide2.
Precision Delivery System
Allows for reproducible placement of the Bulkamid cushions under direct vision.
Efficacious, Durable, Safe
92% of women report being cured or improved at 12 months2, with durability demonstrated at seven years3 and no serious adverse events4.
References:
- Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [published online ahead of print, 2021 Jan 28]. Neurourol Urodyn. 2021;10.1002/nau.24615. doi:10.1002/nau.24615
- Brosche T, et al. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Journal of Neurology and Urodynamics. 2021
- Dwyer et al., “Voice your choice”: A study of women’s choice of surgery for primary stress urinary incontinence. International Urogynecology Journal (2020) 31:769-777
- Itkonen Freitas et al. Tension free vaginal tape vs polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomised controlled trial. Journal of Urology 2020
 Emergo Europe B.V. Westervoortsedijk 60 6827 AT Arnhem The Netherlands |
 2797 |
Questions?
We are here to help answer any questions you may have about Axonics Therapy.
